1. Home
  2. IDYA vs DHT Comparison

IDYA vs DHT Comparison

Compare IDYA & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$35.87

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Logo DHT Holdings Inc.

DHT

DHT Holdings Inc.

N/A

Current Price

$17.84

Market Cap

2.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
IDYA
DHT
Founded
2015
2005
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
2019
2005

Fundamental Metrics

Financial Performance
Metric
IDYA
DHT
Price
$35.87
$17.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
3
Target Price
$52.86
$19.33
AVG Volume (30 Days)
1.4M
3.9M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
5.36%
EPS Growth
61.90
N/A
EPS
N/A
N/A
Revenue
$218,710,000.00
N/A
Revenue This Year
N/A
$8.85
Revenue Next Year
$201.05
N/A
P/E Ratio
N/A
$12.73
Revenue Growth
3024.43
N/A
52 Week Low
$21.33
$10.61
52 Week High
$40.58
$20.55

Technical Indicators

Market Signals
Indicator
IDYA
DHT
Relative Strength Index (RSI) 50.34 47.75
Support Level $32.85 $17.14
Resistance Level $38.17 $18.80
Average True Range (ATR) 1.45 0.69
MACD -0.47 0.02
Stochastic Oscillator 4.70 45.23

Price Performance

Historical Comparison
IDYA
DHT

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About DHT DHT Holdings Inc.

DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.

Share on Social Networks: